Anaptysbio (ANAB) Return on Sales (QoQ) (2016 - 2026)

Anaptysbio (ANAB) Return on Sales (QoQ) (2016 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Anaptysbio 1.58 Bn 1.29 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 -3.00
Dec 31, 2025 0.00
Sep 30, 2025 2.00
Jun 30, 2025 0.00
Mar 31, 2025 -2.00
Dec 31, 2024 3.00
Sep 30, 2024 2.00
Jun 30, 2024 2.00
Mar 31, 2024 -1.00
Dec 31, 2023 7.00
Sep 30, 2023 0.00
Jun 30, 2023 34.00
Mar 31, 2023 -41.00
Dec 31, 2022 25.00
Sep 30, 2022 13.00
Jun 30, 2022 16.00
Mar 31, 2022 -26.00
Dec 31, 2021 -30.00
Sep 30, 2021 0.00
Jun 30, 2021 2.00